Efficacy of metformin on ovulation induction in Asian women with polycystic ovary syndrome

References

• Conway G. Polycystic ovary syndrome: clinical aspects. Bailliere's ClM Endocrinol Metab 1996;10:263–79
   PubMedGoogle Scholar
• Hull MGR. Epidemiology of infertility and poly-cystic ovarian disease: endocrinological and demographicstudies.GynecolEndocrinol1987;1:235–45
   Google Scholar
• Homburg R. Polycystic ovary syndrome: induction of ovulation. Bailliere's Gun Endocrinol Metab 1996;10:281–92
   PubMedGoogle Scholar
• The ESHRE Capri workshop. Female infertility: treatment options for complicated cases. Hum Reprod 1997;12:1191–6
   PubMed Web of Science ®Google Scholar
• Farhi J, Homburg R, Lemer A, et al. The choice of treatment for anovulation following failure to conceive with clomiphene. Hum Rep rod 1993;8:1367–71
   PubMed Web of Science ®Google Scholar
• Weerakiet S, Srisombut C, Choktanasiri W, et al. Efficacy of laparoscopic ovulation induction in polycystic ovary syndrome. J Med Assoc Thai 1999;82:760–4
   PubMedGoogle Scholar
• Duniaf A. Insulin resistance and polycystic ovary syndrome mechanism and implications for patho-genesis (review). Endocr Rev 1997;18:774–800
   PubMed Web of Science ®Google Scholar
• Bailey CJ, Turner RC. Metformin (review). N Engl J Med 1996;334:574–9
   PubMed Web of Science ®Google Scholar
• Pirwany IR, Yates RWS, Cameron IT, et al. Effects of insulin sensitizing drug metformin on ovarian function, follicular growth and ovulation rate in obese women with oligomenorrhea. Hum Reprod 1999;14:2963–8
   PubMed Web of Science ®Google Scholar
• Nestler JE, Jakubowicz DJ, Evans WS, et al. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med 1998;338:1876–80
   PubMed Web of Science ®Google Scholar
• Vandermolen DT, Ratts VS, Evans WS, et al. Metformin increases the ovulatory rate and preg-nancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone. Fertil Steril 2001;75:310–15
   PubMed Web of Science ®Google Scholar
• Parsanezhad ME, Alborzi S, Zarei A, et al. Insulin resistance in clomiphene responders and non-responders with polycystic ovarian disease and therapeutic effects of metformin. Int J Gynecol Obstet. 2001;75:43–50
   PubMed Web of Science ®Google Scholar
• Ng EH, Wat NM, Ho PC. Effects of metformin on ovulation rate, hormonal and metabolic profiles in women with clomiphene-resistant polycystic ovar-ies: a randomized, double-blineded placebo-controlled trial. Hum Reprod 2001;16:1625–31
   Google Scholar
• Kocak M, Caliskan E, Simsir C, et al. Metformin therapy improves ovulatory rates, cervical scores and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome. Fertil Steril 2002;77:101–6
   PubMed Web of Science ®Google Scholar
• Weerakiet S, Srisombut C, Bunnag P, et al. Prevalence of IGT and type 2 DM in Asian women with PCOS. Int J Gynecol Obstet 2001;75:177–84
   PubMed Web of Science ®Google Scholar
• Legro RS, Kunselman AR, Dodson WC, et al. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Gun Endocrinol Metab 1999;84:165–9
   PubMed Web of Science ®Google Scholar
• Homburg R. Polycystic ovary syndrome — from gynecological curiosity to multisystem endocrino-pathy. Hum Reprod 1996;11:29–39
   PubMed Web of Science ®Google Scholar
• Adams J, Polson DW, Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J 1986;293:355–9
   Google Scholar
• Barbieri RL, Makris A, Randall RW, et al. Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyper-androgenism. J Oin Endocrinol Metab 1986;62:904–10
   PubMed Web of Science ®Google Scholar
• Murafawa H, Hasegawa I, Kurabayashi T, et al. Polycystic ovary syndrome. Insulin resistance and ovulatory responses to clomiphene citrate. J Reprod Med 1999;44:23–7
   Google Scholar
• Costello MF, Eden JA. A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome. Fertil Steril 2003;79:1–13
   PubMed Web of Science ®Google Scholar
• Pasquali R, Casimirri F, Vicennati V. Weight control and its beneficial effect on fertility in women with obesity and polycystic ovary syndrome. Hum Reprod 1997;12 (Suppl 1):82–7
   Google Scholar
• Nestler JE, Stovall D, Akhter N, et al. Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome. Fertil Steril 2002;77:209–15
   PubMed Web of Science ®Google Scholar
• Byrd W. Sperm preparation and homologous insemination. In: Keye WR, Chang RJ, Rebar RW, et al., eds. Infertility, Evolution and Treatment. Philadelphia: WB Saunders, 1995:696–711
   Google Scholar
• Attia GR, Rainey WE, Carr BR. Metformin directly inhibits androgen production in human thecal cells. Fertil Steril 2001;76:517–24
   Google Scholar
• Koldziejczyk B, Duleba AJ, Spaczynski RZ, et al. Metformin therapy decreases hyperandrogensim and hyperinsulinemia in women with polycystic ovary syndrome. Fertil Steril 2000;85:139–46
   Google Scholar